Evidence map›Paper›PMID 29315115›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2018

Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression.

Thomas A OʼBryan, Brian K Agan, Russell P Tracy, Matthew S Freiberg, Jason F Okulicz, Kaku So-Armah, Anuradha Ganesan, David Rimland, Tahaniyat Lalani, Robert G Deiss and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Thomas A OʼBryanInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, School of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD.
Brian K AganInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, School of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD.
Russell P TracyDepartment of Pathology, University of Vermont College of Medicine, Burlington, VT.
Matthew S FreibergDivision of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, TN.
Jason F OkuliczInfectious Disease Service, Brooke Army Medical Center, Fort Sam Houston, TX.
Kaku So-ArmahDepartment of Medicine, University of Boston School of Medicine, Boston, MA.
Anuradha GanesanInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, School of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD.
David RimlandDepartment of Medicine, Emory University School of Medicine, Atlanta, GA.
Tahaniyat LalaniInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, School of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD.
Robert G DeissInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, School of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD.
Edmund C TramontNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Uniformed Services University of the Health Sciences · USHenry M. Jackson Foundation · USBoston University · USEmory University · USNational Institute of Allergy and Infectious Diseases · USSan Antonio Military Medical Center · USUniversity of Vermont · USVanderbilt University · US

Funding

Novel Mechanisms Driving Excess Atherosclerotic Cardiovascular Disease Risk in the Context of HIV: The Role of Liver InjuryK01HL134147 · NHLBI · BOSTON MEDICAL CENTER · PI SO-ARMAH, KAKU · 2016 to 2020
$620k
DATA CENTER FOR EPIDEMIOLOGIC INVESTIGATIONS OF HIVN01AI005072 · NIAID · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 1990 to 1994
–
NHLBI NIH HHS K01 HL134147NIAID NIH HHS Y01 AI005072
6 · The paper itself

Abstract

backgroundD-dimer blood levels in persons with HIV infection are associated with risk of serious non-AIDS conditions and death. Black race has been correlated with higher D-dimer levels in several studies. We examined the effects of race and HIV on D-dimer over time and the impact of viral load suppression by longitudinally comparing changes in levels among healthy young adult male African Americans and whites before HIV seroconversion and before and after initiation of antiretroviral therapy (ART).

methodsWe analyzed D-dimer levels and clinical and laboratory data of 192 participants enrolled in the US Military HIV Natural History Study, a 30-year cohort of military personnel infected with HIV. D-dimer levels were measured on stored sera from each participant at 3 time points: (1) before HIV seroconversion (Pre-SC), (2) ≥6 months after HIV seroconversion but before ART initiation (Post-SC), and (3) ≥6 months after ART with documented viral suppression (Post-ART). Levels were compared at each time point using nonparametric and logistic regression analysis.

resultsCompared with whites (n = 106), African Americans (n = 86) had higher D-dimer levels post-SC (P = 0.007), but in the same individuals, pre-SC baseline and post-ART levels were similar (P = 0.40 and P = 0.99, respectively). There were no racial differences in CD4 cell counts, HIV RNA viral load, time from estimated seroconversion to ART initiation, and duration on ART.

conclusionsObserved longitudinally, racial differences in D-dimer levels were seen only during HIV viremia. Higher levels of D-dimer commonly observed in African Americans are likely due to factors in addition to race.

Indexed as

Military PersonnelAdultAnti-HIV AgentsBlack or African AmericanFibrin Fibrinogen Degradation ProductsHIV InfectionsHumansLongitudinal StudiesMaleRNA, ViralSerumUnited StatesViral LoadWhite PeopleYoung AdultAnti-HIV AgentsFibrin Fibrinogen Degradation Productsfibrin fragment DRNA, Viral

Identifiers

PMID29315115
PMCPMC5844843
OpenAlexW2783241658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.